Vanda Pharmaceuticals' patents were infringed upon

A federal judge ruled that Roxane Laboratories infringed on two of Vanda Pharmaceuticals Inc.'s (Nasdaq: VNDA) patents. The stock price soared $2.42 to close at $14.17.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.